Regulators and health technology assessment bodies in the EU are jointly reviewing a proposed framework on how drug and medical device companies can best undertake patient preference studies to support regulatory and HTA decision-making.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?